Skip to main content
. Author manuscript; available in PMC: 2015 Nov 6.
Published in final edited form as: Cell Rep. 2014 Oct 30;9(3):1089–1098. doi: 10.1016/j.celrep.2014.09.053

Figure 3. Effect of Anti-B7x Therapy on Survival and Tumor Rechallenge.

Figure 3

(A) BALB/c mice were iv injected with B7x/CT26 at day 0 and then injected ip with 1H3 or control IgG. At day 60 post-injection, the surviving mice were iv rechallenged with B7x/CT26 (n=10). *p<0.05; **p<0.01. (B) At day 120, surviving mice were sacrificed and lung sections were used for HE staining. Representative lung tissues from surviving and naïve mice are shown. Bar 100µm.